loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for Controlled & Modified Release? Find Controlled & Modified Release Agents used in Cysteamine Bitartrate to address drug delivery challenges on PharmaCompass.

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    View Presentation

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Menu

    Cysteamine Bitartrate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 5Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Evonik

    02 1SPI Pharma

    03 2Aeon Procare

    04 2Alcedo Pharmachem

    05 17BASF

    06 2Gangwal Chemicals

    07 4Ideal Cures Pvt Ltd

    08 14Kerry

    09 1Kima Chemical

    10 1Lonza Capsugel

    11 1Sigachi Industries

    12 2The Dow Chemical Company

    13 3Vertellus

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    Evonik

    Germany
    arrow
    European Coatings Show
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

    Dosage Form : Capsule, Granule / Pellet, Tablet

    Grade : Oral

    Brand Name : EUDRAGIT® L 100-55

    Application : Coating Systems & Additives, Controlled & Modified Release, Solubilizers

    Excipient Details : EUDRAGIT® L 100-55 (powder) is used in delayed release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules & granules.

    Pharmacopoeia Ref : NA

    Technical Specs : NA

    Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer

    Dosage Form : Capsule, Granule / Pellet, Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

    Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer

    Dosage Form : Capsule, Granule / Pellet, Tablet

    Category : Coating Systems & Additives, Controlled & Modified Release, Solubilizers

    Brand : EUDRAGIT® L 100-55

    Applications : EUDRAGIT® L 100-55 (powder) is used in delayed release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules & granules.

    Pharmacopoeia Ref : NA

    Technical Specs : NA

    Grade : Oral

    arrow
    EUDRAGIT® L 100-55

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    02

    SPI Pharma

    U.S.A
    arrow
    World Vaccine Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

    Dosage Form : Tablet

    Grade : Oral

    Brand Name : ACTILLETS™

    Application : Coating Systems & Additives, Controlled & Modified Release

    Excipient Details : ACTILLETS are microcrystalline cellulose spheres developed using advanced drug delivery technology to enable effective loading & coating of particles.

    Pharmacopoeia Ref : NA

    Technical Specs :

    Ingredient(s) : Microcrystalline Cellulose

    Dosage Form : Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

    Ingredient(s) : Microcrystalline Cellulose

    Dosage Form : Tablet

    Category : Coating Systems & Additives, Controlled & Modified Release

    Brand : ACTILLETS™

    Applications : ACTILLETS are microcrystalline cellulose spheres developed using advanced drug delivery technology to enable effective loading & coating of particles.

    Pharmacopoeia Ref : NA

    Technical Specs : Not Available

    Grade : Oral

    arrow
    ACTILLETS™

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    03

    Kerry

    SHEFFCEL

    arrow
    Immuno-Oncology 360
    Not Confirmed

    04

    Ideal Cures Pvt Ltd

    ECOPOL L100 55

    arrow
    Immuno-Oncology 360
    Not Confirmed

    Ideal Cures Pvt Ltd

    India
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Oral

    Brand Name : Ecopol L100 55

    Application : Coating Systems & Additives, Controlled & Modified Release

    Excipient Details : It is a dry powder derived from a 30% aqueous dispersion (ECOPOL L 30 D 55). The major application is for Enteric/Delayed release coating for drug delivery in the duodenum.

    Pharmacopoeia Ref : Monograph - EP, USP, JPE

    Technical Specs :

    Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer

    Dosage Form : Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer

    Dosage Form : Tablet

    Category : Coating Systems & Additives, Controlled & Modified Release

    Brand : ECOPOL L100 55

    Applications : It is a dry powder derived from a 30% aqueous dispersion (ECOPOL L 30 D 55). The major application is for Enteric/Delayed release coating for drug delivery in the duodenum.

    Pharmacopoeia Ref : Monograph - EP, USP, JPE

    Technical Specs : Not Available

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    05

    Aeon Procare

    TALC

    arrow
    Immuno-Oncology 360
    Not Confirmed

    06

    Alcedo Pharmachem

    LUMACRIL L-100D 55

    arrow
    Immuno-Oncology 360
    Not Confirmed

    Alcedo Pharmachem

    India
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule, Tablet

    Grade : Oral

    Brand Name : Lumacril L-100D 55

    Application : Coating Systems & Additives, Controlled & Modified Release, Solubilizers

    Excipient Details : Lumacril L-100D 55 is an anionic copolymer used in delayed & sustained release coatings to enhance solubility for poorly soluble drugs in OSDs.

    Pharmacopoeia Ref : USP-NF, Ph.Eur, BP, JP

    Technical Specs : NA

    Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer

    Dosage Form : Capsule, Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer

    Dosage Form : Capsule, Tablet

    Category : Coating Systems & Additives, Controlled & Modified Release, Solubilizers

    Brand : LUMACRIL L-100D 55

    Applications : Lumacril L-100D 55 is an anionic copolymer used in delayed & sustained release coatings to enhance solubility for poorly soluble drugs in OSDs.

    Pharmacopoeia Ref : USP-NF, Ph.Eur, BP, JP

    Technical Specs : NA

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    07

    Ideal Cures Pvt Ltd

    ECOPOL L 30 D-55

    arrow
    Immuno-Oncology 360
    Not Confirmed

    08

    Kerry

    SHEFFCEL CR

    arrow
    Immuno-Oncology 360
    Not Confirmed

    09

    Ideal Cures Pvt Ltd

    ESPHERES EM

    arrow
    Immuno-Oncology 360
    Not Confirmed

    Ideal Cures Pvt Ltd

    India
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Oral

    Brand Name : Espheres EM

    Application : Controlled & Modified Release

    Excipient Details : These spheres can be used as an inert base for modified release formulations promoting consistency and uniformity of release profile thus ensuring a uniform therapeutic response.

    Pharmacopoeia Ref : Particle Sizes - #20 – #30, ...

    Technical Specs :

    Ingredient(s) : Microcrystalline Cellulose

    Dosage Form : Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Microcrystalline Cellulose

    Dosage Form : Tablet

    Category : Controlled & Modified Release

    Brand : ESPHERES EM

    Applications : These spheres can be used as an inert base for modified release formulations promoting consistency and uniformity of release profile thus ensuring a uniform therapeutic response.

    Pharmacopoeia Ref : Particle Sizes - #20 – #30, #30 – #40 and #40 – #60

    Technical Specs : Not Available

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    10

    Ideal Cures Pvt Ltd

    INSTAMODEL BLEND

    arrow
    Immuno-Oncology 360
    Not Confirmed

    11

    Sigachi Industries

    HICEL MCC SPHERES

    arrow
    Immuno-Oncology 360
    Not Confirmed

    12

    Kerry

    SHEFFCOAT™ S

    arrow
    Immuno-Oncology 360
    Not Confirmed

    13

    The Dow Chemical Company

    METHOCEL™

    arrow
    Immuno-Oncology 360
    Not Confirmed

    The Dow Chemical Company

    U.S.A
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet, Capsule

    Grade :

    Brand Name : METHOCEL™

    Application : API Stability Enhancers, Coating Systems & Additives, Controlled & Modified Release, Direct Compression, Granulation, Rheology Modifiers, Vegetarian Capsules

    Excipient Details : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions

    Pharmacopoeia Ref :

    Technical Specs :

    Ingredient(s) : Hydroxypropyl Methylcellulose

    Dosage Form : Tablet, Capsule

    Grade :

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Hydroxypropyl Methylcellulose

    Dosage Form : Tablet, Capsule

    Category : API Stability Enhancers, Coating Systems & Additives, Controlled & Modified Release, Direct Compression, Granulation, Rheology Modifiers, Vegetarian Capsules

    Brand : METHOCEL™

    Applications : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions

    Pharmacopoeia Ref : Not Available

    Technical Specs : Not Available

    Grade : Not Available

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    14

    Kerry

    SHEFFCOAT™ENHANCE

    arrow
    Immuno-Oncology 360
    Not Confirmed

    15

    Kima Chemical

    HYDROXYPROPYL METHYL CELLULOSE (75K100)

    arrow
    Immuno-Oncology 360
    Not Confirmed

    16

    Kerry

    SHEFFCOAT™ GLIDE

    arrow
    Immuno-Oncology 360
    Not Confirmed

    17

    Kerry

    SHEFFCOAT™ L

    arrow
    Immuno-Oncology 360
    Not Confirmed

    18

    Kerry

    SHEFFCOAT™

    arrow
    Immuno-Oncology 360
    Not Confirmed

    19

    Lonza Capsugel

    VCAPS® ENTERIC

    arrow
    Immuno-Oncology 360
    Not Confirmed

    Lonza Capsugel

    U.S.A
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule

    Grade : Oral

    Brand Name : Vcaps® Enteric

    Application : Controlled & Modified Release, Vegetarian Capsules

    Excipient Details : It offers an enteric-release profile to the upper gastro-intestinal tract that meets the disintegration requirements for delayed-release capsules for the European, US and Japanese Phamacopoeia.

    Pharmacopoeia Ref : Complies with relevant Europea...

    Technical Specs : Water content – less than 6%; Size #0

    Ingredient(s) : HPMC AS, Hydroxypropyl Methyl Cellulose

    Dosage Form : Capsule

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : HPMC AS, Hydroxypropyl Methyl Cellulose

    Dosage Form : Capsule

    Category : Controlled & Modified Release, Vegetarian Capsules

    Brand : VCAPS® ENTERIC

    Applications : It offers an enteric-release profile to the upper gastro-intestinal tract that meets the disintegration requirements for delayed-release capsules for the European, US and Japanese Phamacopoeia.

    Pharmacopoeia Ref : Complies with relevant European, Japanese and US Pharmacopeia monographs

    Technical Specs : Water content – less than 6%; Size #0

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    20

    Kerry

    SHEFFCOAT™ CG

    arrow
    Immuno-Oncology 360
    Not Confirmed

    21

    Kerry

    SHEFFCOAT™ D

    arrow
    Immuno-Oncology 360
    Not Confirmed

    22

    Vertellus

    TRIETHYL CITRATE (TEC)

    arrow
    Immuno-Oncology 360
    Not Confirmed

    Vertellus

    U.S.A
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule, Granule / Pellet, Tablet

    Grade : Oral

    Brand Name : Triethyl Citrate (TEC)

    Application : Coating Systems & Additives, Controlled & Modified Release, Fillers, Diluents & Binders, Film Formers & Plasticizers

    Excipient Details : Controlled-release coatings, Enteric coatings, Plasticizer in acrylic and cellulosic film coatings, Coalescing agent/film former for aqueous latex dispersions, Plasticizer in low-temperature hot-melt extrusion.

    Pharmacopoeia Ref : NF, FCC, JPE

    Technical Specs : Water soluble

    Ingredient(s) : Triethyl Citrate

    Dosage Form : Capsule, Granule / Pellet, Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Triethyl Citrate

    Dosage Form : Capsule, Granule / Pellet, Tablet

    Category : Coating Systems & Additives, Controlled & Modified Release, Fillers, Diluents & Binders, Film Formers & Plasticizers

    Brand : TRIETHYL CITRATE (TEC)

    Applications : Controlled-release coatings, Enteric coatings, Plasticizer in acrylic and cellulosic film coatings, Coalescing agent/film former for aqueous latex dispersions, Plasticizer in low-temperature hot-melt extrusion.

    Pharmacopoeia Ref : NF, FCC, JPE

    Technical Specs : Water soluble

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    23

    Gangwal Chemicals

    POLYQUID PA-100

    arrow
    Immuno-Oncology 360
    Not Confirmed

    24

    Kerry

    SHEFFCOAT™ EC

    arrow
    Immuno-Oncology 360
    Not Confirmed

    25

    Kerry

    SHEFFCOAT™ HS

    arrow
    Immuno-Oncology 360
    Not Confirmed

    26

    Kerry

    SHEFFCOAT™ MP

    arrow
    Immuno-Oncology 360
    Not Confirmed

    27

    BASF

    KOLLICOAT SR 30 D

    arrow
    Immuno-Oncology 360
    Not Confirmed

    BASF

    Germany
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule, Granule / Pellet, Softgel Capsule, Tablet, Topical Film

    Grade :

    Brand Name : Kollicoat SR 30 D

    Application : Coating Systems & Additives, Controlled & Modified Release, Taste Masking

    Excipient Details : pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

    Pharmacopoeia Ref : Ph. Eur.: Poly(vinyl acetate) ...

    Technical Specs :

    Ingredient(s) : Polyvinyl Acetate, Sodium Lauryl Sulfate

    Dosage Form : Capsule, Granule / Pellet, Softgel Capsule, Tablet, Topical Film

    Grade :

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Polyvinyl Acetate, Sodium Lauryl Sulfate

    Dosage Form : Capsule, Granule / Pellet, Softgel Capsule, Tablet, Topical Film

    Category : Coating Systems & Additives, Controlled & Modified Release, Taste Masking

    Brand : KOLLICOAT SR 30 D

    Applications : pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

    Pharmacopoeia Ref : Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

    Technical Specs : Not Available

    Grade : Not Available

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    28

    BASF

    KOLLICOAT MAE 100-55

    arrow
    Immuno-Oncology 360
    Not Confirmed

    BASF

    Germany
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule, Granule / Pellet, Softgel Capsule, Tablet

    Grade :

    Brand Name : Kollicoat MAE 100-55

    Application : Coating Systems & Additives, Controlled & Modified Release

    Excipient Details : Enteric coating with release above pH 5.5 (non-neutralized powder), fast redispersing for aqueaous and organic coating

    Pharmacopoeia Ref :

    Technical Specs :

    Ingredient(s) : Methacrylic Acid & Ethyl Acrylate Copolymer

    Dosage Form : Capsule, Granule / Pellet, Softgel Capsule, Tablet

    Grade :

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Methacrylic Acid & Ethyl Acrylate Copolymer

    Dosage Form : Capsule, Granule / Pellet, Softgel Capsule, Tablet

    Category : Coating Systems & Additives, Controlled & Modified Release

    Brand : KOLLICOAT MAE 100-55

    Applications : Enteric coating with release above pH 5.5 (non-neutralized powder), fast redispersing for aqueaous and organic coating

    Pharmacopoeia Ref : Not Available

    Technical Specs : Not Available

    Grade : Not Available

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    29

    BASF

    KOLLICOAT MAE 100 P

    arrow
    Immuno-Oncology 360
    Not Confirmed

    30

    BASF

    KOLLICOAT MAE 30 DP

    arrow
    Immuno-Oncology 360
    Not Confirmed

    BASF

    Germany
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule, Granule / Pellet, Softgel Capsule, Tablet

    Grade :

    Brand Name : Kollicoat MAE 30 DP

    Application : Coating Systems & Additives, Controlled & Modified Release, Taste Masking

    Excipient Details : Enteric coating with release above pH 5.5 (30 % solids content dispersion)

    Pharmacopoeia Ref : Ph. Eur.: Methacrylic Acid

    Technical Specs :

    Ingredient(s) : Methacrylic Acid & Ethyl Acrylate Copolymer

    Dosage Form : Capsule, Granule / Pellet, Softgel Capsule, Tablet

    Grade :

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Methacrylic Acid & Ethyl Acrylate Copolymer

    Dosage Form : Capsule, Granule / Pellet, Softgel Capsule, Tablet

    Category : Coating Systems & Additives, Controlled & Modified Release, Taste Masking

    Brand : KOLLICOAT MAE 30 DP

    Applications : Enteric coating with release above pH 5.5 (30 % solids content dispersion)

    Pharmacopoeia Ref : Ph. Eur.: Methacrylic Acid

    Technical Specs : Not Available

    Grade : Not Available

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth